• OPEN AN ACCOUNT
Indian Indices
Sensex
78,499.17 -455.59
( -0.58%)
Global Indices
Nasdaq
54,056.75 150.65
(0.28%)
Dow Jones
7,778.11 47.15
(0.61%)
Hang Seng
65,597.55 -85.71
(-0.13%)
Nikkei 225
10,909.12 41.23
(0.38%)
Forex
USD-INR
95.20 0.13
(0.14%)
EUR-INR
109.83 0.08
(0.08%)
GBP-INR
128.13 0.14
(0.11%)
JPY-INR
0.60 0.00
(-0.12%)

EQUITY - MARKET SCREENER

Emcure Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
544210
INE168P01015
195.6288102
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EMCURE
45.3
37501.66
EPS(TTM)
Face Value()
Div & Yield %
43.64
10
0.18
 

Daikaffil Chemicals India reports standalone net loss of Rs 0.89 crore in the March 2026 quarter
May 28,2026
Net Loss of Daikaffil Chemicals India reported to Rs 0.89 crore in the quarter ended March 2026 as against net loss of Rs 0.35 crore during the previous quarter ended March 2025. Sales declined 50.75% to Rs 1.97 crore in the quarter ended March 2026 as against Rs 4.00 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 2.14 crore in the year ended March 2026 as against net loss of Rs 1.59 crore during the previous year ended March 2025. Sales rose 78.00% to Rs 13.35 crore in the year ended March 2026 as against Rs 7.50 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1.974.00 -51 13.357.50 78
OPM %-41.12-10.25 --13.93-24.00 -
PBDT-0.79-0.20 -295 -1.82-1.33 -37
PBT-0.89-0.28 -218 -2.18-1.60 -36
NP-0.89-0.35 -154 -2.14-1.59 -35